Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis.

Alahyari, Sam; Rajaeinejad, Mohsen; Jalaeikhoo, Hasan; Chegini, Leila; Almasi Aghdam, Maryam; Asgari, Ali; Nasiri, Malihe; Khoshdel, Alireza; Faridfar, Ali

Alahyari, Sam; Rajaeinejad, Mohsen; Jalaeikhoo, Hasan; Chegini, Leila; Almasi Aghdam, Maryam; Asgari, Ali; Nasiri, Malihe; Khoshdel, Alireza; Faridfar, Ali.

Affiliation

Alahyari S; Science and Research branch, AJA University of Medical Sciences, Tehran, Iran.
Rajaeinejad M; Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jalaeikhoo H; AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.
Chegini L; AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.
Almasi Aghdam M; Resident of Internal Medicine, Faculty of Medicine Aja University of Medical Sciences, Tehran, Iran.
Asgari A; Department of Pathology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nasiri M; Infectious Diseases Research Center, AJA University of Medical Science, Tehran, Iran.
Khoshdel A; Department of biostatics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Faridfar A; Modern Epidemiology Research Center, Aja University of Medical Sciences, Tehran, Iran.

PLoS One ; 17(8): e0268712, 2022.

Article de En | MEDLINE | ID: mdl-35930526

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: Iran

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google